News

"Longer follow-ups after the pandemic are needed to investigate persistent brain aging effects and their long-term ...
The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...
A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.
Pregnancies in patients on isotretinoin are lower than those on topical retinoids but still occur, despite the iPLEDGE program, and sociodemographic factors may play a role.
Scientists report that a class of drugs, called RNA interference (RNAi) therapeutics, represent a major advancement in the ...
Unilever Consumer Care Limited (UCL), formerly known as GlaxoSmithKline Bangladesh Limited, has announced the appointment of Mohammad Naharul Islam Molla as the new managing director of the company.
Higher UPF-consumption was linked to worse knee OA outcomes among women, including higher pain scores, worse physical function, and thinner knee cartilage.
The global Behcet’s Disease market is projected to grow significantly from 2025 to 2035 due to increasing prevalence and improved diagnosis, particularly in regions such as the Middle East, Asia, and ...
British drugmaker GSK said on Thursday the European Union has approved the company's blood cancer drug Blenrep for the ...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article ...
GSK (GSK) stock in focus as the company secures EU approval for Blenrep combo therapies targeting the blood cancer multiple ...